{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:23:34Z","timestamp":1793726614503,"version":"4.6.1"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Gout arthritis (GA) is a common and curable type of inflammatory arthritis that has been attributed to a combination of genetic, environmental and metabolic factors. Chronic deposition of monosodium urate (MSU) crystals in articular and periarticular spaces as well as subsequent activation of innate immune system in the condition of persistent hyperuricemia are the core mechanisms of GA. As is well known, drugs for GA therapy primarily consists of rapidly acting anti-inflammatory agents and life-long uric acid lowering agents, and their therapeutic outcomes are far from satisfactory. Although MSU crystals in articular cartilage detected by arthrosonography or in synovial fluid found by polarization microscopy are conclusive proofs for GA, the exact molecular mechanism of NLRP3 inflammasome activation in the course of GA still remains mysterious, severely restricting the early diagnosis and therapy of GA. On the one hand, the activation of Nod-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome requires nuclear factor kappa B (NF-\u03baB)-dependent transcriptional enhancement of NLRP3, precursor (pro)-caspase-1 and pro-IL-1\u03b2, as well as the assembly of NLRP3 inflammasome complex and sustained release of inflammatory mediators and cytokines such as IL-1\u03b2, IL-18 and caspase-1. On the other hand, NLRP3 inflammasome activated by MSU crystals is particularly relevant to the initiation and progression of GA, and thus may represent a prospective diagnostic biomarker and therapeutic target. As a result, pharmacological inhibition of the assembly and activation of NLRP3 inflammasome may also be a promising avenue for GA therapy. Herein, we first introduced the functional role of NLRP3 inflammasome activation and relevant biological mechanisms in GA based on currently available evidence. Then, we systematically reviewed therapeutic strategies for targeting NLRP3 by potentially effective agents such as natural products, novel compounds and noncoding RNAs (ncRNAs) in the treatment of MSU-induced GA mouse models. In conclusion, our present review may have significant implications for the pathogenesis, diagnosis and therapy of GA.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1137822","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T01:32:36Z","timestamp":1679880756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":124,"title":["Role of NLRP3 in the pathogenesis and treatment of gout arthritis"],"prefix":"10.3389","volume":"14","author":[{"given":"Ya-ru","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","article-title":"Gout (Primer)","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Nat Reviews: Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05595-w","article-title":"Comorbidities and factors influencing frequent gout attacks in patients with gout: A cross-sectional study","volume":"40","author":"Liang","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/nu11061336","article-title":"Influence of genetic and non-genetic risk factors for serum uric acid levels and hyperuricemia in mexicans","volume":"11","author":"Rivera-Paredez","year":"2019","journal-title":"Nutrients."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205877","article-title":"Twenty-eight loci that influence serum urate levels: Analysis of association with gout","volume":"75","author":"Phipps-Green","year":"2016","journal-title":"Ann rheumatic diseases"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1051682","article-title":"The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment","volume":"12","author":"Tong","year":"2022","journal-title":"Front Cell Infection Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14967","article-title":"Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis","volume":"177","author":"Yin","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S343978","article-title":"Carvacrol alleviates hyperuricemia-induced oxidative stress and inflammation by modulating the NLRP3\/NF-\u03baB pathwayt. drug design","volume":"16","author":"Riaz","year":"2022","journal-title":"Dev Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13937","article-title":"Global burden of gout in 1990-2019: A systematic analysis of the global burden of disease study 2019","volume":"53","author":"Jeong","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/M16-0570","article-title":"Management of acute and recurrent gout: A clinical practice guideline from the American college of physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Internal Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/rheumatology\/key002","article-title":"Gout: State of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3904\/kjim.2018.205","article-title":"Clinical features and recurrent attack in gout patients according to serum urate levels during an acute attack","volume":"35","author":"Lee","year":"2020","journal-title":"Korean J Internal Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"34150","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2013update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.32114","article-title":"Hepatitis e virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable","volume":"75","author":"Li","year":"2022","journal-title":"Hepatology."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638676","article-title":"Decoy receptor 3 inhibits monosodium urate-induced NLRP3 inflammasome activation via reduction of reactive oxygen species production and lysosomal rupture","volume":"12","author":"Pan","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580593","article-title":"Gallic Acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling","volume":"11","author":"Lin","year":"2020","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27204","article-title":"Mechanistic insight into the attenuation of gouty inflammation by Taiwanese green propolis via inhibition of the NLRP3 inflammasome","volume":"234","author":"Hsieh","year":"2019","journal-title":"J Cell Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.643149","article-title":"Inflammasomes and fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.41245","article-title":"Direct binding to NLRP3 pyrin domain as a novel strategy to prevent NLRP3-driven inflammation and gouty arthritis","volume":"72","author":"Yang","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01420","article-title":"Activation and role of NACHT, LRR, and PYD domains-containing protein 3 inflammasome in RNA viral infection","volume":"8","author":"Yu","year":"2017","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP 3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 inflammasome: Activation and regulation","volume":"48","author":"Xu","year":"2022","journal-title":"Trends Biochem Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.smim.2009.05.002","article-title":"The NLRP3 inflammasome: A sensor of immune danger signals","volume":"21","author":"Cassel","year":"2009","journal-title":"Semin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4176","article-title":"NLRP3 inflammasome and lipid metabolism analysis based on UPLC-Q-TOF-MS in gouty nephropathy","volume":"44","author":"Zhang","year":"2019","journal-title":"Int J Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.630536","article-title":"Nuclear receptors in the control of the NLRP3 inflammasome pathway","volume":"12","author":"Duez","year":"2021","journal-title":"Front Endocrinology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9687925","DOI":"10.1155\/2022\/9687925","article-title":"Relevance of NLRP3 inflammasome-related pathways in the pathology of diabetic wound healing and possible therapeutic targets","volume":"2022","author":"Ding","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.01.003","article-title":"Inflammasome activation and IL-1\u03b2 and IL-18 processing during infection","volume":"32","author":"Van de Veerdonk","year":"2011","journal-title":"Trends Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2741\/3462","article-title":"Neutrophil-derived serine proteases modulate innate immune responses","volume":"14","author":"Meyer-Hoffert","year":"2009","journal-title":"Front Bioscience-Landmark"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2017.01.004","article-title":"Whole-body vibration of mice induces progressive degeneration of intervertebral discs associated with increased expression of il-1\u03b2 and multiple matrix degrading enzymes","volume":"25","author":"McCann","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"B34","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: Emerging mechanisms and effector functions","volume":"165","author":"Rathinam","year":"2016","journal-title":"Cell."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1265","article-title":"Role of interleukin-1 inhibitors in the management of gout","volume":"33","author":"Tran","year":"2013","journal-title":"Pharmacotherapy: J Hum Pharmacol Drug Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S351660","article-title":"ATP-activated P2X7R promote the attack of acute gouty arthritis in rats through activating NLRP3 inflammasome and inflammatory cytokine production","volume":"15","author":"Dai","year":"2022","journal-title":"J Inflammation Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.644121","article-title":"Protective or harmful: The dual roles of autophagy in diabetic retinopathy","volume":"8","author":"Gong","year":"2021","journal-title":"Front Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591803","article-title":"Interplay between NLRP3 inflammasome and autophagy","volume":"2470","author":"Biasizzo","year":"2020","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888306","article-title":"Inflammatory response to regulated cell death in gout and its functional implications","volume":"1566","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2007.04.004","article-title":"The inflammasome, autoinflammatory diseases, and gout","volume":"74","author":"P\u00e9trilli","year":"2007","journal-title":"Joint Bone Spine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/imr.12833","article-title":"Urate-induced immune programming: Consequences for gouty arthritis and hyperuricemia","volume":"294","author":"Cab\u0103u","year":"2020","journal-title":"Immunol Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.69","article-title":"The emerging role of neutrophils in autoimmune-associated disorders: Effector, predictor, and therapeutic targets","volume":"2","author":"Fu","year":"2021","journal-title":"MedComm."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202388","article-title":"Neutrophil extracellular trap\u2013associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages","volume":"190","author":"Kahlenberg","year":"2013","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-013-0361-0","article-title":"Neutrophils, IL-1\u03b2, and gout: is there a link","author":"Mitroulis","year":"2013","journal-title":"In.Seminars immunopathology: Springer;"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/molecules26041071","article-title":"Loganin alleviates gout inflammation by suppressing NLRP3 inflammasome activation and mitochondrial damage","volume":"26","author":"Choi","year":"2021","journal-title":"Molecules."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220295","article-title":"Mechanosensitive TRPV4 is required for crystal-induced inflammation","volume":"80","author":"Lan","year":"2021","journal-title":"Ann Rheumatic Diseases"},{"key":"B47","doi-asserted-by":"publisher","first-page":"114405","DOI":"10.1016\/j.bcp.2021.114405","article-title":"Purinergic signalling in host innate immune defence against intracellular pathogens","volume":"187","author":"Coutinho-Silva","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.abb.2019.06.010","article-title":"Chaetocin attenuates gout in mice through inhibiting HIF-1\u03b1 and NLRP3 inflammasome-dependent IL-1\u03b2 secretion in macrophages","volume":"670","author":"Wu","year":"2019","journal-title":"Arch Biochem biophysics"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: Mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2013.1429","article-title":"Polymorphisms in the NLRP3 gene and risk of primary gouty arthritis corrigendum in\/mmr\/8\/6\/1888","volume":"7","author":"Meng","year":"2013","journal-title":"Mol Med Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4238\/2015.December.9.10","article-title":"Investigation on the association between NLRP3 gene polymorphisms and susceptibility to primary gout","volume":"14","author":"Wang","year":"2015","journal-title":"Genet Mol Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0802-3","article-title":"Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout","volume":"17","author":"McKinney","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3900-6","article-title":"Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese han population","volume":"37","author":"Zhang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B54","article-title":"rs3806268 of NLRP3 gene polymorphism is associated with the development of primary gout","volume":"8","author":"Deng","year":"2015","journal-title":"Int J Clin Exp pathology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1427607","DOI":"10.1155\/2022\/1427607","article-title":"NLRP3 susceptible gene polymorphisms in patients with primary gouty arthritis and hyperuricemia","volume":"2022","author":"Zhang","year":"2022","journal-title":"BioMed Res Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07895-z","article-title":"The interplay between HLA-b and NLRP3 polymorphisms may be associated with the genetic susceptibility of gout","volume":"49","author":"Fern\u00e1ndez-Torres","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6054069","DOI":"10.1155\/2018\/6054069","article-title":"Artemisia extract suppresses NLRP3 and AIM2 inflammasome activation by inhibition of ASC phosphorylation","volume":"2018","author":"Kwak","year":"2018","journal-title":"Mediators Inflamm"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.07.087","article-title":"Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7","volume":"517","author":"Kim","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.676297","article-title":"A purified biflavonoid extract from selaginella moellendorffii alleviates gout arthritis via NLRP3\/ASC\/Caspase-1 axis suppression","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5541232","DOI":"10.1155\/2022\/5541232","article-title":"3\u03b2, 23-Dihydroxy-12-ene-28-ursolic acid isolated from cyclocarya paliurus alleviates NLRP3 inflammasome-mediated gout via PI3K-AKT-mTOR-Dependent autophagy","volume":"2022","author":"Lou","year":"2022","journal-title":"Evidence-Based Complementary Altern Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2017.11.023","article-title":"Actinidia arguta extract attenuates inflammasome activation: Potential involvement in NLRP3 ubiquitination","volume":"213","author":"Heo","year":"2018","journal-title":"J ethnopharmacology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.760331","article-title":"Active flavonoids from lagotis brachystachya attenuate monosodium urate-induced gouty arthritis via inhibiting TLR4\/MyD88\/NF-\u03baB pathway and NLRP3 expression","volume":"12","author":"Ouyang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/medicina57090898","article-title":"Ameliorative effects of cardamonin on monosodium urate-induced gouty arthritis through inhibiting nlrp3 inflammasome mediation","volume":"57","author":"Wang","year":"2021","journal-title":"Medicina."},{"key":"B64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/JME-20-0305","article-title":"NLRP3 inflammasome inhibitor cucurbitacin b suppresses gout arthritis in mice","volume":"67","author":"Xue","year":"2021","journal-title":"J Mol endocrinology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"104348","DOI":"10.1016\/j.phrs.2019.104348","article-title":"Coptisine from coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1","volume":"147","author":"Wu","year":"2019","journal-title":"Pharmacol Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.intimp.2016.12.031","article-title":"Berberine, an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats","volume":"44","author":"Dinesh","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"8868527","DOI":"10.1155\/2021\/8868527","article-title":"Cichoric acid ameliorates monosodium urate-induced inflammatory response by reducing NLRP3 inflammasome activation via inhibition of NF-kB signaling pathway","volume":"2021","author":"Wang","year":"2021","journal-title":"Evidence-Based Complementary Altern Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"153398","DOI":"10.1016\/j.phymed.2020.153398","article-title":"Celastrol ameliorates propionibacterium acnes\/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3","volume":"80","author":"Yan","year":"2021","journal-title":"Phytomedicine."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-019-1974-z","article-title":"Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of I\u03baB\u03b1 and blocking mitochondrial damage","volume":"21","author":"Chen","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27969","article-title":"Curcumin ameliorates monosodium urate-induced gouty arthritis through nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa b signaling","volume":"120","author":"Li","year":"2019","journal-title":"J Cell Biochem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.651305","article-title":"\u03b2-caryophyllene ameliorates MSU-induced gouty arthritis and inflammation through inhibiting NLRP3 and NF-\u03baB signal pathway: In silico and in vivo","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2072055","article-title":"Cynarin suppresses gouty arthritis induced by monosodium urate crystals","volume":"13","author":"Wu","year":"2022","journal-title":"Bioengineered."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2147\/DDDT.S343978","article-title":"Carvacrol alleviates hyperuricemia-induced oxidative stress and inflammation by modulating the NLRP3\/NF-\u03baB pathwayt","volume":"16","author":"Riaz","year":"2022","journal-title":"Drug Design Dev Ther"},{"key":"B74","doi-asserted-by":"publisher","first-page":"153521","DOI":"10.1016\/j.phymed.2021.153521","article-title":"Baeckein e suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: Implications for gout therapy","volume":"84","author":"Lin","year":"2021","journal-title":"Phytomedicine."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01076","article-title":"A sesquiterpene lactone from viguiera robusta, alleviates pain and inflammation in a model of acute gout arthritis in mice","volume":"9","author":"Fattori","year":"2018","journal-title":"Front Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.07.023","article-title":"Doliroside a attenuates monosodium urate crystals-induced inflammation by targeting NLRP3 inflammasome","volume":"740","author":"Wei","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.739953","article-title":"Erianin: A direct NLRP3 inhibitor with remarkable anti-inflammatory activity","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-021-03364-5","article-title":"Effects of stephania hainanensis alkaloids on MSU-induced acute gouty arthritis in mice","volume":"21","author":"Fan","year":"2021","journal-title":"BMC Complementary Med Therapies"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1955-1","article-title":"Effects of mollugo pentaphylla extract on monosodium urate crystal-induced gouty arthritis in mice","volume":"17","author":"Lee","year":"2017","journal-title":"BMC complementary Altern Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s11418-021-01571-5","article-title":"Effects of gentiopicroside on activation of NLRP3 inflammasome in acute gouty arthritis mice induced by MSU","volume":"76","author":"He","year":"2022","journal-title":"J Natural medicines"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.799552","article-title":"(\u2013)-Epicatechin ameliorates monosodium urate-induced acute gouty arthritis through inhibiting NLRP3 inflammasome and the NF-\u03baB signaling pathway","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600106","article-title":"Epigallocatechin gallate inhibits urate crystals-induced peritoneal inflammation in C57BL\/6 mice","volume":"60","author":"Jhang","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1652244","DOI":"10.1155\/2022\/1652244","article-title":"Corilagin restrains NLRP3 inflammasome activation and pyroptosis through the ROS\/TXNIP\/NLRP3 pathway to prevent inflammation","volume":"2022","author":"Luo","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B84","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.3390\/molecules27113477","article-title":"The protective effects of neoastilbin on monosodium urate stimulated THP-1-Derived macrophages and gouty arthritis in mice through NF-\u03baB and NLRP3 inflammasome pathways","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules."},{"key":"B85","doi-asserted-by":"publisher","first-page":"108107","DOI":"10.1016\/j.intimp.2021.108107","article-title":"Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation","volume":"100","author":"Wang","year":"2021","journal-title":"Int Immunopharmacology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12868","article-title":"Wedelolactone facilitates Ser\/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis","volume":"53","author":"Pan","year":"2020","journal-title":"Cell proliferation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"111413","DOI":"10.1016\/j.biopha.2021.111413","article-title":"Total glucosides of paeony protects THP-1 macrophages against monosodium urate-induced inflammation via MALAT1\/miR-876-5p\/NLRP3 signaling cascade in gouty arthritis","volume":"138","author":"Meng","year":"2021","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.02.004","article-title":"Targeting inflammatory mediators with ferulic acid, a dietary polyphenol, for the suppression of monosodium urate crystal-induced inflammation in rats","volume":"148","author":"Doss","year":"2016","journal-title":"Life Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep38622","article-title":"Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: A novel strategy to treat acute gout","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.2147\/JIR.S320912","article-title":"Resveratrol relieves gouty arthritis by promoting mitophagy to inhibit activation of NLRP3 inflammasomes","volume":"14","author":"Fan","year":"2021","journal-title":"J Inflammation Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10787-018-00555-4","article-title":"Resveratrol ameliorates gouty inflammation via upregulation of sirtuin 1 to promote autophagy in gout patients","volume":"27","author":"Yang","year":"2019","journal-title":"Inflammopharmacology."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X19500071","article-title":"Rhein, an anthraquinone drug, suppresses the NLRP3 inflammasome and macrophage activation in urate crystal-induced gouty inflammation","volume":"47","author":"Chang","year":"2019","journal-title":"Am J Chin Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"9748338","DOI":"10.1155\/2022\/9748338","article-title":"Exploring the mechanism through which phyllanthus emblica l. extract exerts protective effects against acute gouty arthritis: A network pharmacology study and experimental validation","volume":"2022","author":"Tao","year":"2022","journal-title":"Evidence-Based Complementary Altern Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01123","article-title":"Trans-chalcone attenuates pain and inflammation in experimental acute gout arthritis in mice","volume":"9","author":"Staurengo-Ferrari","year":"2018","journal-title":"Front Pharmacol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"114322","DOI":"10.1016\/j.jep.2021.114322","article-title":"Leojaponin inhibits NLRP3 inflammasome activation through restoration of autophagy via upregulating RAPTOR phosphorylation","volume":"278","author":"Zhang","year":"2021","journal-title":"J Ethnopharmacology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"288","DOI":"10.14202\/vetworld.2022.288-298","article-title":"Immunosuppression by piperine as a regulator of the NLRP3 inflammasome through MAPK\/NF-\u03baB in monosodium urate-induced rat gouty arthritis","volume":"15","author":"Jati","year":"2022","journal-title":"Vet World"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0849-y","article-title":"Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression","volume":"14","author":"Liu","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-020-00758-8","article-title":"Management of gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: Targeting IL-1\u03b2 and cathepsin b in macrophages","volume":"28","author":"Qiao","year":"2020","journal-title":"Inflammopharmacology."},{"key":"B99","doi-asserted-by":"publisher","first-page":"211932","DOI":"10.2147\/DDDT.S356307","article-title":"Palmatine protects against MSU-induced gouty arthritis via regulating the NF-\u03baB\/NLRP3 and Nrf2 pathways","volume":"16","author":"Cheng","year":"2022","journal-title":"Drug Design Dev Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2019.1590721","article-title":"Pharmacological basis for use of madecassoside in gouty arthritis: Anti-inflammatory, anti-hyperuricemic, and NLRP3 inhibition","volume":"41","author":"Lu","year":"2019","journal-title":"Immunopharmacol Immunotoxicology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7514","article-title":"Polysaccharide extract from isatidis radix inhibits multiple inflammasomes activation and alleviate gouty arthritis","volume":"36","author":"Ren","year":"2022","journal-title":"Phytotherapy Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11418-020-01440-7","article-title":"Preventive effect of dioscin against monosodium urate-mediated gouty arthritis through inhibiting inflammasome NLRP3 and TLR4\/NF-\u03baB signaling pathway activation: An in vivo and in vitro study","volume":"75","author":"Han","year":"2021","journal-title":"J Natural medicines"},{"key":"B103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phymed.2018.03.007","article-title":"4-(2-(4-chlorophenyl)-1-((4-chlorophenyl) amino) ethyl) benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3","volume":"42","author":"Zhou","year":"2018","journal-title":"Phytomedicine."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.990469","article-title":"Exploring the mechanism of action of dapansutrile in the treatment of gouty arthritis based on molecular docking and molecular dynamics","volume":"1828","author":"Cao","year":"2022","journal-title":"Front Physiol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1664-2","article-title":"NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis","volume":"20","author":"Marchetti","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2020.02.007","article-title":"Discovery of novel and potent P2Y14R antagonists via structure-based virtual screening for the treatment of acute gouty arthritis","volume":"23","author":"Wang","year":"2020","journal-title":"J advanced Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"113933","DOI":"10.1016\/j.ejmech.2021.113933","article-title":"Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2Y14R antagonists with anti-gout potential","volume":"227","author":"Zhou","year":"2022","journal-title":"Eur J Medicinal Chem"},{"key":"B108","doi-asserted-by":"publisher","first-page":"113313","DOI":"10.1016\/j.ejmech.2021.113313","article-title":"Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis","volume":"216","author":"Lu","year":"2021","journal-title":"Eur J Medicinal Chem"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2018.02.013","article-title":"Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout","volume":"26","author":"Huang","year":"2018","journal-title":"Bioorganic Medicinal Chem"},{"key":"B110","doi-asserted-by":"publisher","first-page":"126944","DOI":"10.1016\/j.bmcl.2019.126944","article-title":"Development of novel NLRP3-XOD dual inhibitors for the treatment of gout","volume":"30","author":"Wang","year":"2020","journal-title":"Bioorganic Medicinal Chem Letters"},{"key":"B111","doi-asserted-by":"publisher","first-page":"107375","DOI":"10.1016\/j.intimp.2021.107375","article-title":"Curcumin analogue AI-44 alleviates MSU-induced gouty arthritis in mice via inhibiting cathepsin b-mediated NLRP3 inflammasome activation","volume":"93","author":"Gu","year":"2021","journal-title":"Int Immunopharmacology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.imlet.2022.03.003","article-title":"A small molecule inhibitor of caspase-1 inhibits NLRP3 inflammasome activation and pyroptosis to alleviate gouty inflammation","volume":"244","author":"Cao","year":"2022","journal-title":"Immunol Letters"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.8b00959","article-title":"Hesperidin methylchalcone suppresses experimental gout arthritis in mice by inhibiting NF-\u03baB activation","volume":"66","author":"Ruiz-Miyazawa","year":"2018","journal-title":"J Agric Food Chem"},{"key":"B114","doi-asserted-by":"publisher","first-page":"102696","DOI":"10.1016\/j.jbc.2022.102696","article-title":"Spirodalesol analog 8A inhibits NLRP3 inflammasome activation and attenuates inflammatory disease by directly targeting adaptor protein ASC","volume":"298","author":"Liu","year":"2022","journal-title":"J Biol Chem"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.979939","article-title":"Z1456467176 alleviates gouty arthritis by allosterically modulating P2X7R to inhibit NLRP3 inflammasome activation","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2609-7","article-title":"P2Y14 receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death disease"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2021.1874696","article-title":"Long non-coding RNA HOTAIR knockdown alleviates gouty arthritis through miR-20b upregulation and NLRP3 downregulation","volume":"20","author":"Liu","year":"2021","journal-title":"Cell Cycle"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-021-01483-2","article-title":"Circular RNA circHIPK3 activates macrophage NLRP3 inflammasome and TLR4 pathway in gouty arthritis via sponging miR-561 and miR-192","volume":"44","author":"Lian","year":"2021","journal-title":"Inflammation."},{"key":"B119","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/cei.13587","article-title":"MiR-223-3p inhibits inflammation and pyroptosis in monosodium urate-induced rats and fibroblast-like synoviocytes by targeting NLRP3","volume":"204","author":"Tian","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/1756-185X.14089","article-title":"MiR-223-3p and miR-22-3p inhibit monosodium urate-induced gouty inflammation by targeting NLRP3","volume":"24","author":"Wang","year":"2021","journal-title":"Int J Rheumatic Diseases"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1546-7","article-title":"Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome","volume":"20","author":"Zhang","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00229","article-title":"Silencing of gasdermin d by siRNA-loaded PEI-chol lipopolymers potently relieves acute gouty arthritis through inhibiting pyroptosis","volume":"18","author":"Ye","year":"2020","journal-title":"Mol Pharmaceutics"},{"key":"B123","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.7150\/ijbs.46153","article-title":"Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis","volume":"16","author":"Hao","year":"2020","journal-title":"Int J Biol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1137822\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T01:32:43Z","timestamp":1679880763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1137822\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":123,"alternative-id":["10.3389\/fimmu.2023.1137822"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1137822","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"article-number":"1137822"}}